These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Nutrient interaction with drugs and other xenobiotics. Hayes JR; Borzelleca JF J Am Diet Assoc; 1985 Mar; 85(3):335-9. PubMed ID: 3973324 [TBL] [Abstract][Full Text] [Related]
43. The role of metabonomics at the interface between drug metabolism and safety assessment. Waters NJ Curr Drug Metab; 2010 Oct; 11(8):686-92. PubMed ID: 20973758 [TBL] [Abstract][Full Text] [Related]
44. Physiological defence against xenobiotics at their portals of entry to the organism. Hänninen O; Aitio A; Hietanen E Med Biol; 1979 Oct; 57(5):251-5. PubMed ID: 392204 [TBL] [Abstract][Full Text] [Related]
45. Research in the Division of Toxicology. The importance of reactive intermediates of drug biotransformation in drug toxicity. Mulder GJ Pharm Weekbl Sci; 1985 Apr; 7(2):67-70. PubMed ID: 4000901 [TBL] [Abstract][Full Text] [Related]
46. Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism. Baillie TA; Rettie AE Drug Metab Pharmacokinet; 2011; 26(1):15-29. PubMed ID: 20978360 [TBL] [Abstract][Full Text] [Related]
48. Enzymology of human cytosolic sulfotransferases. Falany CN FASEB J; 1997 Mar; 11(4):206-16. PubMed ID: 9068609 [TBL] [Abstract][Full Text] [Related]
49. Biotransformation of drugs and other xenobiotics during postnatal development. Klinger W Pharmacol Ther; 1982; 16(3):377-429. PubMed ID: 6752980 [No Abstract] [Full Text] [Related]
50. Idiosyncratic toxicity: the role of toxicophores and bioactivation. Williams DP; Park BK Drug Discov Today; 2003 Nov; 8(22):1044-50. PubMed ID: 14690635 [TBL] [Abstract][Full Text] [Related]
51. Drugs and the liver. Papich MG; Davis LE Vet Clin North Am Small Anim Pract; 1985 Jan; 15(1):77-95. PubMed ID: 3872507 [TBL] [Abstract][Full Text] [Related]
52. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Rushmore TH; Kong AN Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894 [TBL] [Abstract][Full Text] [Related]
54. Cytochrome P450 systems--biological variations of electron transport chains. Hannemann F; Bichet A; Ewen KM; Bernhardt R Biochim Biophys Acta; 2007 Mar; 1770(3):330-44. PubMed ID: 16978787 [TBL] [Abstract][Full Text] [Related]
55. Abstracts from the 14th North American ISSX (International Society for the Study of Xenobiotics)Meeting, October 22-26, 2006, Rio Grande, Puerto Rico, USA. Drug Metab Rev; 2006; 38 Suppl 2():1-258. PubMed ID: 17378085 [No Abstract] [Full Text] [Related]
56. Drug-induced hepatotoxicity. Lee WM N Engl J Med; 1995 Oct; 333(17):1118-27. PubMed ID: 7565951 [No Abstract] [Full Text] [Related]
57. Biotransformation of xenobiotics in the fetus. Pelkonen O Pharmacol Ther; 1980; 10(2):261-81. PubMed ID: 6997899 [No Abstract] [Full Text] [Related]
58. The biochemistry of drug metabolism--an introduction: part 4. reactions of conjugation and their enzymes. Testa B; Krämer SD Chem Biodivers; 2008 Nov; 5(11):2171-336. PubMed ID: 19035562 [TBL] [Abstract][Full Text] [Related]
59. Detection of metabolites using high-performance liquid chromatography and mass spectrometry. McClure TD Curr Protoc Toxicol; 2001 May; Chapter 4():Unit4.4. PubMed ID: 20945295 [TBL] [Abstract][Full Text] [Related]
60. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators. Knights KM; Miners JO Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]